All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1 Billion TWD | -151.05% |
| 2022 | -399.04 Million TWD | 7.01% |
| 2021 | -429.12 Million TWD | 39.81% |
| 2020 | -712.96 Million TWD | 11.23% |
| 2019 | -803.12 Million TWD | -101.8% |
| 2018 | -397.97 Million TWD | 53.94% |
| 2017 | -864.1 Million TWD | -175.18% |
| 2016 | -314.01 Million TWD | -292.54% |
| 2015 | 163.08 Million TWD | 54.38% |
| 2014 | 105.64 Million TWD | -55.08% |
| 2013 | 235.2 Million TWD | 146.29% |
| 2012 | 95.5 Million TWD | 324.79% |
| 2011 | -42.48 Million TWD | 36.86% |
| 2010 | -67.29 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -961.59 Million TWD | 4.01% |
| 2024 Q2 | -746.51 Million TWD | 22.37% |
| 2023 Q4 | -1 Billion TWD | -4.4% |
| 2023 Q3 | -959.54 Million TWD | -33.08% |
| 2023 Q2 | -721.04 Million TWD | 0.63% |
| 2023 Q1 | -725.62 Million TWD | -81.84% |
| 2023 FY | -1 Billion TWD | -151.05% |
| 2022 FY | -399.04 Million TWD | 7.01% |
| 2022 Q4 | -399.04 Million TWD | -48.41% |
| 2022 Q3 | -268.87 Million TWD | 0.04% |
| 2022 Q2 | -268.99 Million TWD | 2.79% |
| 2022 Q1 | -276.7 Million TWD | 35.52% |
| 2021 FY | -429.12 Million TWD | 39.81% |
| 2021 Q1 | -667.14 Million TWD | 6.43% |
| 2021 Q2 | -738.74 Million TWD | -10.73% |
| 2021 Q3 | -451.46 Million TWD | 38.89% |
| 2021 Q4 | -429.12 Million TWD | 4.95% |
| 2020 FY | -712.96 Million TWD | 11.23% |
| 2020 Q2 | -773.65 Million TWD | -16.32% |
| 2020 Q3 | -798.59 Million TWD | -3.22% |
| 2020 Q4 | -712.96 Million TWD | 10.72% |
| 2020 Q1 | -665.11 Million TWD | 17.18% |
| 2019 Q1 | -492.5 Million TWD | -23.75% |
| 2019 Q3 | -764.34 Million TWD | -12.27% |
| 2019 FY | -803.12 Million TWD | -101.8% |
| 2019 Q2 | -680.81 Million TWD | -38.24% |
| 2019 Q4 | -803.12 Million TWD | -5.07% |
| 2018 Q2 | -317.39 Million TWD | 26.57% |
| 2018 FY | -397.97 Million TWD | 53.94% |
| 2018 Q4 | -397.97 Million TWD | -39.08% |
| 2018 Q3 | -286.14 Million TWD | 9.85% |
| 2018 Q1 | -432.24 Million TWD | 49.98% |
| 2017 FY | -864.1 Million TWD | -175.18% |
| 2017 Q1 | -262.04 Million TWD | 16.55% |
| 2017 Q2 | -458.07 Million TWD | -74.81% |
| 2017 Q3 | -538.49 Million TWD | -17.56% |
| 2017 Q4 | -864.1 Million TWD | -60.47% |
| 2016 FY | -314.01 Million TWD | -292.54% |
| 2016 Q4 | -314.01 Million TWD | -365.74% |
| 2016 Q3 | 118.16 Million TWD | -33.75% |
| 2016 Q2 | 178.36 Million TWD | -52.61% |
| 2016 Q1 | 376.41 Million TWD | 130.8% |
| 2015 FY | 163.08 Million TWD | 54.38% |
| 2015 Q4 | 163.08 Million TWD | 0.0% |
| 2015 Q1 | 524.72 Million TWD | 0.0% |
| 2014 FY | 105.64 Million TWD | -55.08% |
| 2013 Q1 | 183.51 Million TWD | 185.81% |
| 2013 FY | 235.2 Million TWD | 146.29% |
| 2012 FY | 95.5 Million TWD | 324.79% |
| 2012 Q4 | -213.86 Million TWD | 0.0% |
| 2011 FY | -42.48 Million TWD | 36.86% |
| 2010 FY | -67.29 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Sinon Corporation | -38.98 Million TWD | -2469.714% |
| Taiwan Fertilizer Co., Ltd. | -4.2 Billion TWD | 76.166% |
| CH Biotech R&D Co., Ltd. | -94.76 Million TWD | -957.1% |